Replies to post #72578 on Biotech Values

[genisi]

AZD3480 nicotinic receptor agonist phase II
LY2062430 (solanezumab) anti-amyloid mAb phase II

[bladerunner1717]

Masterlongevity,

I think COR still has a Phase II going on somewhere; we haven't heard much about it all recently. I don't think you missed much.

Bladerunner

[murko]

MK -0249 Merk, undisclosed target,oral, P2
Rosiglitazone, GSK,oral ,P3
SSR180711- Sanofi, neuronal nicotinic receptor, oral, P2
Raloxifene- Lilly, SERM, oral, P2

[DewDiligence]

The phase-2 trial of ponezumab (PF-04360365) comparing monthly and tri-monthly dosing at 10mg/kg has been completed: http://clinicaltrials.gov/ct2/show/NCT00945672 . This drug is hardly ever discussed.